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Microwave gallium-68 radiochemistry for
kinetically stable bis(thiosemicarbazone)
complexes: structural investigations and cellular
uptake under hypoxia†
Israt S. Alam,a Rory L. Arrowsmith,‡b Fernando Cortezon-Tamarit,‡b
Frazer Twyman,‡a Gabriele Kociok-Köhn,b Stanley W. Botchway,c
Jonathan R. Dilworth,d Laurence Carroll,*a Eric O. Aboagye*a and Soﬁa I. Pascu*b
We report the microwave synthesis of several bis(thiosemicarbazones) and the rapid gallium-68 incorporation
to give the corresponding metal complexes. These proved kinetically stable under ‘cold’ and ‘hot’ biological
assays and were investigated using laser scanning confocal microscopy, ﬂow cytometry and radioactive cell
retention studies under normoxia and hypoxia. 68Ga complex retention was found to be 34% higher in
hypoxic cells than in normoxic cells over 30 min, further increasing to 53% at 120 min. Our data suggests that
this class of gallium complexes show hypoxia selectivity suitable for imaging in living cells and in vivo tests by
microPET in nude athymic mice showed that they are excreted within 1 h of their administration.
Introduction
The aqueous radiochemistry of Group 13 metals has become a
matter of paramount importance in the design of new imaging
agents anchored onto unusual metallic radioisotopes for PET
(gallium-68) or SPECT (indium-111).1–3 To date however, there
have been relatively few gallium labelling reactions that do not
consist of the well-established NOTA or DOTA core.4
Gallium-68 complexes have the potential to be extremely
useful in clinical imaging, due to their rapid radiosynthesis
and easy availability of the isotope from on-site generators
(then making it cost eﬀective and simple to use, by analogy to
99mTc). Gallium-68 also has a rather short half-life (t1/2 =
68 min), preventing the exposure of the patient to any larger
dose of radiation than is required for the imaging procedure.
Hypoxia is the term used to describe low oxygen concen-
trations present in a specific environment and has a large
impact on the development and subsequent treatment of a
number of disease types, including cancer. The lack of oxygen
usually indicates there is poor vascularisation within a tumour
and this is, additionally causing the delivery of chemothera-
peutic drugs to the target to become rather challenging. A
number of these agents also interact with oxygen, making
their activation impossible under hypoxia.5–7 Eﬀective radio-
therapy also requires molecular oxygen which acts as a potent
chemical radiosensitiser, thus hypoxia renders cells more
resistant to treatment.8,9 As such, patients with hypoxic
tumours have a lower survival rate, and its early identification
is of great interest to the clinical community. Direct methods
of diagnosis such as biopsy are highly invasive to the patient,
and in recent years positron emission tomography (PET)
imaging has taken the lead in the identification of hypoxic
regions in vivo as a non-invasive imaging method.10
The detection of hypoxia using PET imaging has been deve-
loped over the past twenty years since the discovery of nitroimid-
azoles in the mid-1980s, with subsequent research moving
into metal-containing complexes. The current gold standards
for tumour hypoxia imaging are [18F]FMISO and [64Cu]Cu-
ATSM. Despite their obvious utility, both have significant draw-
backs: [18F]FMISO suﬀers from a low log P and no active
uptake mechanism, leading to long imaging protocols to allow
for suﬃcient uptake in the desired tissue and good signal-to-
background ratios. [64Cu]Cu-ATSM has high liver uptake,
making tumours in the lower gastrointestinal region challen-
ging to distinguish from background. There have been recent
developments elucidating some of the uncertainties with its
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suspected mechanism, and even with provocative clinical data
demonstrating the ability of [64Cu]Cu-ATSM to delineate
therapy “responders” from “non-responders” in multiple
tumour types, its activity in vivo is currently under discussion
within the wider imaging community.11–18
Along with altering the metal centre, we recently discovered
that a modification of the ligand backbone to include a
naphtyl group allows for an intrinsic fluorescence. Prior to our
work there were only very few ligand systems which could give
invaluable information on intracellular distribution that PET
isotopes alone cannot provide. As this ligand system contains
N/S hard/soft donor centres similar to H2ATSM (which has dis-
played hypoxia selective retention for 64CuATSM in vitro in con-
trast to 64Cu(OAc)2 alone, whereas both display similar hypoxia
selectivity in vivo, hypoxia selectivity of any new complex would
need to be explored.18–21
Despite the diﬀering coordination chemistry possessed by
gallium(III) vs. copper(II), we propose that a bis(thiosemicarb-
azonato) complex is an attractive target in allowing access to
new kinetically stable bifunctional gallium-chelators (Fig. 1)
and their radiolabelled analogues in this family.
Results and discussion
Microwave-assisted synthesis
The synthesis of mono and bis(thiosemicarbazones) using
microwave assisted heating conditions was investigated
(Scheme 1). Despite being a common method in organic syn-
thesis, particularly involving nucleophilic substitution reac-
tions, microwave synthesis has been little used in the
synthesis of thiosemicarbazones and not applied in the syn-
thesis of acenaphthenequinone thiosemicarbazones and their
radiochemistry before.22,23
Compounds 1–4 (as well as their Me-functionalised deriva-
tives, see ESI†) were successfully obtained by applying micro-
wave assisted reaction conditions. In comparison with the
conventional heating procedure, this rapid method led to for-
mation of thiosemicarbazones in comparable yields for the
case of the mono(thiosemicarbazone) ligands 1 and 2 and
with significantly higher yields in the case of bis(thiosemicarb-
azones) 3 and 4. Also, the reaction time was reduced from
3–4 h to just under 10 min (see information in ESI†). The
applicability of microwave heating in the synthesis of mono
and bis(thiosemicarbazones) has been demonstrated and
should be the method of choice in future such conversions.
Furthermore, the cyclisation of thiosemicarbazide starting
materials, a process which occurred frequently as a side-reac-
tion upon prolonged heating (which limited the bis(thiosemi-
carbazonate) ligand and complexes formation yield and
caused diﬃculties in purification) did not occur under the
microwave synthesis. The transmetallation reaction from cold
Zn(3) and Zn(4) to their gallium equivalents was also per-
formed under microwave conditions, but in this case the
overall yields did not seem particularly improved with respect
to conventional heating. However, the reaction time was vastly
improved from several hours heating to just under 10 min.
The optimisation of the reaction conditions in the synthesis of
the corresponding gallium complexes by microwave remain
under investigation (Table 1).
Solution and solid-state characterisation of ‘cold’ ligands and
complexes
1H-NMR spectroscopy indicated the high purity of the ligand
precursors and that the bis(substituted) compounds showed
an asymmetric conformation. Fig. 2 shows the 1H-NMR
Scheme 1 Synthesis of mono and bis(thiosemicarbazones) via micro-
wave assisted heating.
Table 1 Reaction conditions for the µW synthesis of ligands 1–4
Conventional synthesis Microwave synthesis
Comp. T/°C t/min Yield T/°C t/min Yield
1 78 180 85% 90 9 73%
2 63% 77%
3 85% 90%
4 74% 94%
Fig. 1 Schematic representative structure of [64Cu]Cu-ATSM and the
structure of mono-substituted and bis-substituted ligand precursors to
the target [68Ga]Ga-BTSC complexes studied herein.
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spectra of proligands 1 and 3 in d6-DMSO. Distinctive nitro-
gen-bonded protons (referred to as NH) for both mono(substi-
tuted) and bis(substituted) ligand precursors appear between
8.8 and 12.9 ppm. The (E,Z) NH resonances can be assigned
accurately for the bis(substituted) ligand precursor, due to the
characteristic resonances corresponding to the mono(substi-
tuted) proligand, which has been determined crystallographi-
cally to represent the Z geometry. In the case of compound 3
and 4 (R = allyl) bis(substituted) proligand resonances analo-
gous to the mono(substituted) ligand precursor for between
12.5 and 12.7 ppm are representative of the Z hydrazone
proton, with shifts between 9.1 and 9.4 ppm corresponding to
external Z proton. This indicates that shifts of the E nitrogen-
bound hydrogen atoms are upfield of their Z counterparts,
with resonances between 11.2 and 11.3 ppm (hydrazonal) and
8.8 and 9.1 ppm (external).
To gain an ultimate proof into the precise nature of the syn-
thesised species, we performed the X-ray structure determi-
nation of the ligands and complexes isolated from the parallel
‘cold’ synthesis.
Crystals of gallium complex 3, bis(thiosemicarbazonato)
ligand precursor 4 and of a sulphur–sulphur dimerised form
of compound 3 suitable for X-ray crystallographic analysis were
grown from DMSO solutions (Fig. 2–4). The proligand 4 was
found to be the unsymmetric (E,Z) isomer unlike several other
related known compounds incorporating CvN bonds such as
bis(alklimino)acenaphthene (alkyl-BIAN) precursors, where the
(E,E) geometry was observed. Cowley et al. had reported (E,Z)
alkyl-BIAN proligand isomers, suggesting that the observed
geometry was due to the substituents steric eﬀects, imino-
nitrogen lone pair repulsion and crystal packing, which could
explain the isomerism displayed by compounds Ga(3) and
Ga(4).24 Structures reported by Besenyei et al. also showed that
aryl(BIAN) derivatives may be observed as either (E,E) (major
isomer) or (E,Z) isomers depending on the polarity of the
solvent.25 Furthermore, Dilworth et al. reported a benzil bis-
(phenylthiosemicarbazone) ligand precursor and related pro-
ligand, which display an (E,E) and a (Z,Z) geometry
respectively.26
A dimerised structure of the ethyl-functionalised bis(substi-
tuted) ligand precursor has been formed via sulphur–sulphur
bridging: single crystals occurred from aqueous DMSO solu-
tions over a prolonged period, and structure was elucidated by
X-ray crystallography. The capacity for DMSO to favour the for-
mation of disulphide bonds in peptides containing cysteine is
well-known.27 Previously reported thiosemicarbazone disul-
phide-bridged ligand precursors were formed by oxidation via
a metal-based catalyst. It has been well documented that Cu(II)
and Fe(III) oxidise organo-thiols to produce sulphur–sulphur
bonds.18 Cu(II)- and Mn(II)-catalysed thiosemicarbazone
sulphur-bridged proligand were reported by López-Torres et al.
and Bermejo et al. respectively (Fig. 3).28,29 The S–S bond
lengths of these published ligand precursors were correspond-
ingly 2.034(11) Å and 2.039(1) Å, which is somewhat shorter
than the disulphide bond of the compound 3 dimer, 2.051(2)
Å. This suggests that the proligand 3 dimer bond may be labile
Fig. 2 1H NMR spectroscopy of the aromatic and amino NH shifts of
compounds 1 and 3 in the 7.5 to 13 ppm region.
Fig. 3 ORTEP representations at 50% probability of dimer of ethyl-
substituted bis(thiosemicarbazonato) ligand compound 3.
Fig. 4 ORTEP representations at 50% probability of allyl-functionalised
bis(thiosemicarbazonato) ligand compound 4.
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and the dimer formation is reversible. This is not unexpected
on basis of interchange onto thiol disulphide dynamic combi-
natorial chemistry and related dynamic exchange (Fig. 5).30
Compound Ga(4) showed similar bond lengths and angles
to those found in a methyl-functionalised mono(thiosemicarb-
azonato) ligand precursor reported previously by Pascu et al.31
Interestingly, the coordination mode of the ligands were found
to be asymmetric in the solid state structures of both Ga(3)
and Ga(4). All complexes display a distorted square pyramidal
structure around the metal centre with the chlorine atom in
the axial position with the base formed by two nitrogen atoms
and two sulphur atoms.
All bond lengths and angles of the ligands within Ga(3) and
Ga(4) complexes are close to those determined for their
reported Zn(II) precursors. It is likely that that the rigid back-
bone and tight control of the ligand bite angles by the pres-
ence of the aromatic naphthyl substituents in complexes Ga(3)
and Ga(4) may account for the significantly higher kinetic
stability of aromatic gallium complexes with respect to
aliphatic analogues. This trend is consistent with what was
found previously for the aromatic Cu(II) analogues.28,29,32,33
Optical spectroscopy and cellular imaging with ‘cold’ gallium
complexes
The naphthyl backbone of the ligand precursors provides elec-
tron-rich π-bonds and facilitates fluorescence emission. There-
fore, fluorescence and UV-vis spectroscopies and confocal and
epi-fluorescence imaging techniques allowed the monitoring
of the fluorescent compounds in solution and biologically in
living cells. This intrinsic fluorescence of the ‘cold’ species
bypassed the necessity of conjugating the metal complexes
with commercially available fluorophores, such as fluorescein
or BODIPY, as we found that such conjugates are often
diﬃcult to synthesise and significantly aﬀect the biological
properties of the compound under investigation.
Appropriate biological assays and microscopy conditions
were chosen once the fluorescent properties of the ligand pre-
cursors and complexes are understood in solution. Therefore,
fluorescence excitation scans and corresponding fluorescence
emission scans between 200–800 nm were obtained for stock
solutions of 100 in µM DMSO. Furthermore, ranges of absorp-
tion and emission were assessed using 2D contours, which
haven used as tools in subsequent choice of cytotoxicity assays
and fluorescence imaging settings. The fluorescence of the
bis(substituted) free ligands 3 and 4 was very weak, with the
overall range of absorption for these compounds approxi-
mately between 260 nm and 550 nm and an emission range of
450 nm and 680 nm (see ESI† for further information)
(Table 2).
The wavelengths resulting in maximum excitation (λex-max)
were found between 470 to 490 nm, indicating that com-
pounds would be appropriate for excitation via the 488 nm
laser of a confocal microscope. A kinetic stability estimation
was conducted in vitro for the ligand precursors in order to
allow comparisons with the previously reported corresponding
metal complexes. Complexes Ga(3) and Ga(4) showed to be
suﬃciently stable in the timescale of the imaging experiment
with respect to decomposition in a mixture of DMSO and
several aqueous buﬀers (see the ESI† for further details) which
are of relevance to standard cellular imaging assays (Fig. 6).
Additionally, it is generally accepted that prior to perform-
ing hypoxia selectivity tests in cellular environments, the redox
chemistry of complexes based upon the ATSM core needs to be
assessed in solution, since it has been ascertained that their
biologically accessible E1/2 is a critical parameter in explaining
the diﬀerences between identical ligands with diﬀering metal
centres (i.e. copper versus zinc, nickel). It was noticed that
ligand 3-bound Copper(II) has an E1/2 of −0.54 V, almost identi-
cal with that of the Cu(II) ATSM hypoxia tracer, however, that
did not show hypoxia selectivity on a 1 h experiment timescale
including [64Cu](3).
In this case, the redox chemistry of the gallium complexes
of the ligands 3 and 4 was also tested by cyclic voltammetry
using a standard three-electrode electrochemical setup in dry
and degassed DMF, adding tetrabutylammonium hexafluoro-
phosphate as supporting electrolyte in a 0.1 M concentration
and ferrocene as an internal standard. For complexes present
in a 1 mM concentration, no oxidation or reduction waves
were observed for Ga(3) or Ga(4) in the cyclic voltammograms,
suggesting these complexes would likely be stable to redox pro-
cesses inside normal redox potentials found in cells. This is as
Fig. 5 ORTEP representation of Ga(3), ellipsoids drawn at 50% prob-
ability; note hydrogen atoms were omitted for clarity.
Table 2 Fluorescence spectroscopy data of bis(thiosemicarbazonato)
ligand precursors and complexes in DMSO at a concentration of 100 µM
Compound
λex-max/
nm
Excitation
range/nm
λem-max/
nm
Emission
range/nm
2 490 240–615 554 454–735
3 490 380–530 550.5 496–663
4 480 260–560 547 499.5–695
Ga(3) 500 250–270 556 500–685
Ga(4) 520 250–550 554 490–690
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expected given their close structural similarity to the redox-
chemistry inert Zn(II) species anchored onto N/S. Unlike in the
case of CuATSM, where the redox process is associated to the
release of copper and hence to the hypoxia selectivity, gallium
does not undergo a redox process to be released in vitro. Once
in the cell the metal would be trapped by one of the potent
iron chelators such as DFO found in cells and ultimately,
gallium would be tracking changes in iron metabolism that
are established to change under hypoxia.31
In vitro imaging experiments were carried out by confocal
multiphoton laser scanning microscopy, coupled with fluo-
rescence lifetime imaging (excitation at 810 nm and 910 nm),
which ascertained that (although weak) the fluorescence emis-
sion of the ligand precursors and corresponding complexes as
suﬃcient to be observed in vitro. Cells were cultured using the
analogous protocols to earlier investigations on fluorescent
thiosemicarbazones (ESI). The compounds were loaded into
EMT6 (breast cancer), HeLa (cervical carcinoma), PC-3 (pros-
tate carcinoma), MCF-7 (breast cancer) as well as FEK-4 (non-
cancerous fibroblast) cell lines and imaged using standard
confocal fluorescence microscopy using single-photon exci-
tation at 488 nm. The imaging studies were performed using
concentrations of 50 µM in a DMSO : RPMI cell medium 1 : 99
solvent mix, whereby the final DMSO concentration on the
imaging plate was lower than 1%. Fig. 7 shows representative
images in the series and full details of the imaging assays are
given in ESI.† (Fig. 8).
Experiments showed that the bis(substituted) free-ligand 4
possessed weak uptake in HeLa cells, which was barely detect-
able when incubated in FEK-4 cells, under the same con-
ditions in contrast to the strong uptake seen with Ga(4) (see
ESI† for further information). The weak fluorescence of the
ligand precursor within cells constitutes a significant advan-
tage in being able to assess the stability of their respective
metal complexes in vitro in that significant emission using
concentrations below 100 µM would be indicative of presence
of the complex rather than the ligand precursor.
An initial investigation to assess the hypoxic selectivity of
the gallium complex Ga(4) was carried out in EMT6 and PC-3
cell lines using flow cytometry (Fig. 9). Interestingly, whilst the
changes seen were small, a significant decrease in fluo-
rescence was observed in both EMT6 and PC-3 cell lines under
hypoxia than observed under normoxia, (17% lower for EMT6
(*P < 0.05, p = 0.0204) and 22% lower in PC-3 cells
(***P < 0.001, p = 3.2512 × 10−6)). The most likely explanation
for the reduction in fluorescence is that the gallium metal
centre is decomplexed from the molecule, leaving the free
ligand and what is assumed to be gallium hydroxide (since the
experiment was carried out in 96% aqueous buﬀer), neither of
which have any noticeable fluorescent signal from experiments
described earlier. These results suggest that there is a definite
eﬀect as a result of hypoxic conditions, thus further in vitro
characterisation was carried out using radiochemical retention
experiments.
Ga-68 radiochemical synthesis
General procedures for the chemical synthesis of the Zn(II) pre-
cursors required for 68Ga labelling under prolonged heating
conitions has been described previously for R = allyl and an
optimised procedure was carried out here as a control. 68Ga
Fig. 6 Excitation/emission 2D map of Ga(3) (above) and Ga(4) (below)
in DMSO at a 100 µM concentration.
Fig. 7 Representative confocal ﬂuorescence imaging of the complex
Ga(4) at 50 μM in 0.5% DMSO, for 20 min, at 37 °C continuous illumina-
tion experiment at 488 nm in MCF-7 breast cancer cells: before
irradiation (a and b) and after irradiation (c and d) for ca. 10 min, where
DIC image (a, c), micrograph of cells after excitation at 488 nm (b, d,
compound, green channel).
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radiolabelling was carried out on both free proligand precur-
sors the corresponding zinc-chelated complexes (Scheme 2).
68Ga was eluted from a generator containing 68Ge using 0.1 M
HCl, before being reformulated into a solution containing
acetone or dry THF and 0.02 M HCl. When this was used
directly for radiolabelling, only free 68Ga was identified, and it
appeared as though all of the ligand starting material had
been degraded in the UV spectra. To counteract this, the com-
plete drying the 68Ga solution to remove all acetone and HCl
using a stream of dry N2 or Ar (at 110 °C on a heating block)
was carried out as these traces of solvent/acid appeared to
interfere with thiosemicarbazone formation. The 68Ga residue,
trapped onto the walls of the borosilicate glass test-tube used,
was re-dissolved in neat ethanol or dry THF. Depending on the
reaction scale, brief sonnication helped ensure that most of
the 68Ga embedded within the glass walls is solubilised, and
this procedure was carried out under a static atmosphere of Ar
(pH ca. 7–8 was adjusted using NaOAc). The complex was sub-
sequently added in DMSO and gave a successful incorporation
of 89% of compound [68Ga]4 (n = 6; decay-corrected for the
allyl variant of the complex) from its zinc-metallated analogue.
Further labelling experiments gave the ethyl variant in a
50% d.c. yield of compound [68Ga]3 when the conventional
heating strategy was used (in a glass vial, on a heating block
held at 90 °C).
In a similar fashion, both ethyl and allyl variants of the
modified bis(thiosemicarbazone) backbone without zinc pre-
complexed gave moderate radiochemical incorporations of
68Ga, with d.c. yields of 36% and 58% respectively. When the
reaction time was increased from 30 to 45 min, incorporation
of 68Ga increased from 89 to 95%, but the increased time (and
therefore decay) negated any potential advantage to this. Total
synthesis time was found to be around 60 min, making it
appropriate for its use in biological investigations, as it is
within one half-life of 68Ga.
Interestingly, we found that when radiolabelling with 68Ga
was carried out by transmetallation from a zinc-chelated 3 via
microwave under Argon and using EtOH or THF as the solvent
of choice, the reaction went to completion within 10 min,
giving a radiochemical incorporation over 95%. This suggested
that gallium-chelation reactions, carried out under kinetic
Fig. 8 Flow cytometry results of ‘cold’ compound Ga(4) in (a) EMT6
and (b) PC-3 cells under hypoxic (white bars) and normoxic (black bars)
conditions. Hypoxia in cells was induced for 20 min prior to addition of
compound in 1% O2 and for a further 20 min in the same conditions
post addition of the compound. Data shown are median ﬂuorescence
intensities (MFU) ± SD (n = 3, samples run in triplicates). MFU values are
in arbitrary units (a.u.). (Exc, λ = 490 nm; Em, λ = 525 nm, x-axis). Stain-
ing is signiﬁcantly lower in cells incubated under hypoxic conditions
than under normoxic conditions for both EMT6 (*P < 0.05, p = 0.0204)
and PC-3 (***P < 0.001, p = 3.2512 × 10−6) cell lines. For both cell lines a
signiﬁcant diﬀerence in ﬂuorescence was observed under hypoxia vs..
normoxia (*P < 0.05 and ***P < 0.001).
Fig. 9 Overlay of the UV-HPLC trace (black) and the radio-HPLC trace
(red) for the radiolabelling experiments; (a) conventional synthesis,
30 min reaction time, (b) microwave synthesis, 10 min reaction time and
(c) microwave synthesis, 10 min reaction time scale up for micro PET
experiments.
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control as it is the case for radiochemical incorporations,
could be sped up significantly when using a microwave reactor
instead of traditional heating. This process was scaled up to
the use of 111 MBq gallium-68 precursor, and the product iso-
lated by a semi-prep HPLC to allow for in vivo imaging by
micro PET. As a result of the significant reduction in radio-
chemical process, the entire radiolabelling procedure includ-
ing semi-prep purification and concentration of the [68Ga]4
radio-tracer under reduced pressure (by rota evaporator) and
pH adjustment (using NaOAc buﬀer, to 8.4) rendered this
tracer ready for in vivo PET imaging experiments in less than
2 h (ESI).
To probe the kinetic stability of the 68Ga-labelled com-
pounds, we carried out several standard assays of relevance to
tracer preparation for in vivo imaging. Citric acid (1 hour, 75%
parent compound with respect to decomposition to free
hydrated gallium ions), EDTA (1 hour, 40% parent compound
with respect to decomposition to free hydrated gallium ions),
and saline/PBS (upto 4 hours, >99% parent compound remain-
ing) were all used to look at the stability of the labelled
complex [68Ga]4. Over 24 hours in an aqueous environment,
isomerisation equilibria occurs as suggested by HPLC traces
(Rt = 7 min, 8.5 min and 10 min), in a ratio of approximately
1 : 1 : 1. When any of these individual fractions was collected
by semi-prep HPLC and re-injected on the HPLC for analysis,
using the same method after 1 hour, the formation of the orig-
inal, parent compound (Rt = 10 min) was observed. Sub-
sequent 1H NMR experiments involving non-labelled gallium
complexes complemented this study and confirmed the exist-
ence of several isomers in aqueous solution, most likely influ-
enced by protonation of the complex under HPLC conditions
(H2O/CH3CN, TFA) (ESI) (Fig. 10).
For a direct comparison to the tracers in clinical trial for
hypoxia, the 68Ga labelling of Zn-ATSM (a typical precursor for
the formation of [64Cu]Cu-ATSM) was attempted using the
same reaction conditions. Despite numerous attempts and
subsequent variations, no product could be identified by
HPLC, with only free hydrated 68Ga ions present at 2–3 min by
radio HPLC. This strengthens the need for a modified back-
bone to the bis(thiosemicarbazonato) structure for the in-
corporation of gallium, to allow for a higher kinetic stability
with respect to association/dissociation post-radiolabelling.
Radiochemical in vitro assays with gallium-68 complexes
The complex [68Ga]4, radiolabelled as described and then puri-
fied via solid phase extraction, was incubated with EMT6 cells
under normoxia and hypoxia (induced as described in ESI,†
and compared with standard hypoxia assays). During the time
of the experiment, aliquots were isolated, centrifuged and the
radioactivity associated with the resulting pellet estimated
with a well counter. Subsequently a time course of the Ga-68
labelled compound 4 retention was analysed. Control experi-
ments were also performed using 68GaCl3 as-made from the
generator to eliminate the possibility that the active species
may be the dissociated ligand-free aqueous 68Gallium(III). At
each time point, there was a significant increase in 68Ga reten-
tion under hypoxia compared to normoxia, with the diﬀerence
being as high as 53% after 2 hours (p = 0.02360) (Fig. 11). The
Scheme 2 68Ga radiolabelling of compounds [68Ga]3 and [68Ga]4.
Fig. 10 Proposed coordination isomers of the bis(thiosemicarbazone)
ligand to the metal centre. A and B forms were observed by X-ray crys-
tallography and NMR. C is considered but not isolated or characterised.
All species were observed in HPLC and radio HPLC.
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EMT6 model has been used extensively in previous studies
with [64Cu]Cu-ATSM, giving a 500% increase in retention
between hypoxic and normoxic cells (in part, due to the extre-
mely low retention observed in normoxic tissue), which is
most likely indicative that [68Ga]4 log P is significantly greater
than that of [64Cu]Cu-ATSM, leading to a higher background
signal and lower diﬀerential, which increases from 30 min
through to 120 min, albeit at a lower level than the increase in
hypoxic retention.
Strikingly, the experiments clearly show a response to
hypoxia which is measureable and statistically significant. This
was unexpected due to the chemical and redox diﬀerences in
the copper(II) and gallium(III) variants of this family of com-
plexes. Experiments were also carried out using [68Ga]GaCl3
under similar conditions, which showed minimal retention,
with no diﬀerences between hypoxia and normoxia, proving
that the retention seen for [68Ga]4 is at least partially ligand-
controlled rather than simply any gallium biological pathway.
As the complexes described within this report are structurally
similar to that of Cu-ATSM and its related family of com-
pounds, conclusions on the possible mechanism of selectivity
could be drawn, despite the change in metal co-ordination
centre from copper to gallium. In the case of Cu-ATSM, recent
work has shown that the ligand backbone system is required
to get hypoxia selectivity in vitro but simple [64Cu]Cu(OAc)2
gives identical hypoxia selectivity in vivo.12,14 As indicated in
the data we have acquired using flow cytometry, it appears
likely that our Ga-BTSC complexes are able to pass inside the
cell, leading to dissociation upon hypoxia. How these obser-
vations will translate in vivo is currently diﬃcult to predict,
with knowledge of any gallium pathways in biology much
more limited than that of copper pathways, but work is on-
going to try and elucidate this. Preliminary in vivo testing in
mice using [68Ga]4 showed rapid excretion through the
bladder (5 min–1 h) and only a slight accumulation in liver
after 4 hours imaging observation (see ESI† for further
details), similar to the distribution seen when using uncom-
plexed [68Ga]GaCl3.
Conclusions
Although hypoxia has been a key area of PET tracer research
since the introduction of [18F]FMISO in 1984, the desired
‘knockout’ hypoxia tracer remains to be discovered. The pro-
blems indicated with current gold standards, both emergent
from this work and within the current literature show that the
clinic is still waiting for a robust, reliable and eﬀective hypoxia
radiotracer that can be routinely used and give results within a
60 minute PET scan.
The data presented here suggests that a symbiosis of the
short-lived isotope gallium-68 and the ligand family of
aromatic bis(thiosemicarbazones) could bring this quest a step
closer towards completion with the advancements in radio-
synthesis due to microwave technologies. Gallium generators
are now wide-spread throughout hospitals in GMP radiophar-
macies, and the possibility of delivering the tracer to the clini-
cian within one half-life and getting decisive in vivo retention
within a further 90 min suggests it is worth pursuing.
To summarise, we have successfully synthesised several
[68Ga]Ga-BTSC analogues, having already looked at their struc-
ture and co-ordination using X-ray crystallography. Further-
more, non-labelled chemistry work using 1H NMR,
fluorescence microscopy and cyclic voltammetry add to the
picture of kinetic stability in biological media in the timescale
of the imaging experiment and shed some light into the bio-
logical fate of the complexes, while both flow cytometry and
68Ga radiochemical retention assays strongly indicate that
there is hypoxic retention response of these complexes, when
compared to simple [68Ga]GaCl3 and [
64Cu]Cu-ATSM retention.
Work is now on-going in two directions in our laboratories: (1)
pursuing the lead compound [68Ga]4 in vivo to look at its reten-
tion in diﬀering tumour models and conditions and (2)
further investigations into the mechanism of this complex in
light of recent publications discussing the mechanism and
selectivity of [64Cu]Cu-ATSM against [64Cu]Cu(OAc)2.
Experimental section
All reagents were purchased from Sigma-Aldrich, Alfa-Aesar,
Merck Chemicals or Acros Organics and were used as received
unless otherwise stated. Microwave reactions were performed
in a Biotage Initiator 2.5 system in 5 mL glass capped vials.
The reaction mixture was prestirred for 30 s and then heated
for the selected time. If the irradiation power is not set, it
reaches its maximum (300 W from magnetron at 2.45 GHz) at
Fig. 11 [68Ga]4 retention in EMT6 cells under hypoxic (white bars) or
normoxic conditions (black bars) was measured at 30, 60 and 120 min
post addition of tracer and is expressed as % of total tracer/mg of
protein. Hypoxia in cells was induced for 20 min prior to addition of the
tracer in 1% O2 and cells were maintained under the same conditions for
the remainder of the time course. Higher retention is observed under
hypoxic conditions. Data represents mean values ± SD (n = 3),
(*P < 0.05, p values at 30, 60 and 120 min are 0.04235, 0.0367 and
0.02360 respectively).
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the start of the reaction until the target temperature is
reached, decreasing to lower values afterwards. 1H NMR
spectra were recorded on a Bruker Avance spectrometer
(300 MHz, 400 MHz) or a Bruker Avance II+ (500 MHz) spectro-
meter at 298 K. Chemical shifts δ in ppm were referenced to
the solvent residual peak as an internal standard. Peak multi-
plicities are given as follows: s, singlet; d, doublet; t, triplet; q,
quartet; qt, quintet and m, multiplet. 13C NMR was recorded
on a Bruker Avance spectrometer (300 MHz, 400 MHz) or a
Bruker Avance II+ (500 MHz) and spectra was referenced to the
solvent residual peak.
Mass spectrometry was performed in a Bruker Micromass
LCT TOF spectrometer under conditions of electrospray ioniza-
tion. Accurate masses are reported to the fourth decimal place
using tetraoctylammonium bromide (466.5352 Da) as an
internal standard.
HPLC was carried out using a Phenomenex Ultracarb C-18
column (4.6 × 150 mm) with UV/visible detection measured at
up to four wavelengths; λobs = 254 nm. The gradient elution
was 1.0 mL per minute, with 0.1% TFA MilliQ water as solvent
A and 0.1% TFA MeOH as solvent B. Start 95% A reverse gradi-
ent until 5% A at 12 min, hold until 15 min.
UV-visible spectra were obtained using a Lamda 650 Perkin-
Elmer Spectrometer in DMSO and processed using UV Winlab
3 software. The orientation of the 1.00 cm quartz cuvette was
the same for each experiment for consistency.
Fluorescence spectra were measured in a LS55 Perkin-Elmer
luminescence spectrophotometer using a 1.00 cm quartz
cuvette. A scan from 200–800 nm with increments of 10 nm
was initially carried out to discover excitation wavelength of
maximum emission (λex-max).
General procedure for microwave-assisted synthesis, A: ace-
naphthenequinone (0.200 g, 1.04 mmol) and the corres-
ponding thiosemicarbazide (1.04 mmol) were suspended in
5 mL of ethanol in a microwave vial. Then, 3 drops of conc.
HCl added were added and the vial was sealed. The reaction
mixture was prestirred for 30 s and then heated to 90 °C for
9 min. The yellow solid was filtered whilst hot, resuspended in
hot methanol, stirred for 15 min, washed with methanol and
diethyl ether and dried under vacuum.
General procedure for microwave-assisted synthesis, B: ace-
naphthenequinone (0.200 g, 1.04 mmol) and the corres-
ponding thiosemicarbazide (3.12 mmol) were suspended in
5 mL of ethanol in a microwave vial. Then, the procedure con-
tinues as in A.
Compound 1 was prepared following the method of Pascu
et al. 2010 (ref. 20) and by microwave synthesis, general pro-
cedure A (216.5 mg, 73%). Compound 2 was prepared follow-
ing the method of Pascu et al. 2011 (ref. 21) and by microwave
synthesis, general procedure A (237.2 mg, 77%).
Bis(4-ethyl-3-thiosemicarbazone) acenaphthenequinone (3).
Acenenaphthenequinone (0.25 g, 0.137 mmol) and 4-ethyl-3-
thiosemicarbazide (0.48 g, 0.411 mmol) were suspended in
40 mL ethanol and refluxed for 4 h. 10 drops of conc. HCl
were added upon reflux. The solid was isolated by filtration
whilst hot, resuspended in hot methanol (10 mL) and stirred
for 15 min before filtering and washing with further methanol.
The resultant yellow solid (446.7 mg, 85%), compound 3, was
dried under vacuum. Microwave synthesis: method B
(359.0 mg, 90%).
1H NMR (300 MHz, d6-DMSO, 25 °C): δ 12.55 (s, 1H,
N-NH′), 11.21 (s, 1H, N-NH), 9.19 (t, 1H, NH′Et, J = 6.0 Hz),
8.80 (t, 1H, NHEt, J = 5.5 Hz), 8.19 (d, 1H, H-1, J = 7.2 Hz), 8.13
(d, 1H, H-3′, J = 8.3 Hz), 8.09 (d, 1H, H-1′, J = 7.0 Hz), 8.03 (d,
1H, H-3, J = 8.3 Hz), 7.79 (overlapping t, 2H, H-2 and H-2′),
3.66 (m, 4H, CH2CH3), 1.24 (m, 6H, CH2CH3).
13C NMR
(75.5 MHz, d6-DMSO, 25 °C): δ 178.77, 176.92, 139.25, 139.16,
136.66, 133.06, 130.04, 128.69, 128.58, 128.12, 128.35, 126.17,
124.64, 119.60, 31.05. Mass spectrum ESI-MS Calc. for
C18H19N6S2 [M − H]− 383.1113, found 383.1155. Elemental
Analysis: Found C; 56.1%, H, 5.23%, N; 21.8%. Calc.:
C; 56.22%, H; 5.24%, N; 21.86%.
Bis(4-allyl-3-thiosemicarbazone) acenaphthenequinone (4).
Acenaphthenequinone (0.25 g, 0.137 mmol) and 4-allyl-3-thio-
semicarbazide (0.54 g, 0.411 mmol) were suspended in 40 mL
ethanol and refluxed for 4 h. 10 drops of conc. HCl were added
upon reflux. The solid was isolated by filtration whilst hot,
resuspended in hot methanol (10 mL) and stirred for 15 min
before filtering and washing with further methanol. The resul-
tant yellow solid 4 (415 mg, 74%) was dried under vacuum.
Microwave synthesis: method B (402.4 mg, 94%).
1H NMR: (300 MHz, d6-DMSO, 25 °C): δ 12.63 (s,1H,
N-NH′), 11.27 (s,1H, N-NH), 9.32 (t, 1H, NHAllyl, J = 6.0 Hz),
9.02 (t, 1H, NH′Allyl, J = 5.7 Hz), 8.21 (d, 1H, H-1 or H-1′, J =
7.2 Hz), 8.11 (overlapping d, 2H, H-3 and H-3′), 8.01 (d, 1H,
H-1 or H-1′, J = 7.1 Hz), 7.80 (overlapping t, 1H, H-2 or H-2′),
7.78 (overlapping t, 1H, H-2 or H-2′), 5.95 (m, 2H, CH2CHCH2)
5.35 + 529 (ddt, 2H, H trans, J = 17.4 Hz), 5.25 + 5.18 (ddt, 2H,
H trans, J = 17.4 Hz), 5.17 + 5.14 (m, 2H, Hcis, J = 10.6 Hz),
4.31 (m, 4H, CH2CHCH2).
13C NMR: (75.5 MHz, d6-DMSO,
25 °C): δ 182.52, 178.14, 138.23, 136.45, 134.86, 134.40, 133.21,
130.32, 129.28, 128.88, 128.55, 128.18, 127.09, 124.93, 116.83,
116.28, 47.07, 46.52. Mass spectrum ESI-MS Calc. for
C20H19N6S2 [M − H]− 407.1113; found 407.1106. Elemental
Analysis: Found C; 58.9%, H; 4.94%, N; 20.5%. C20H20N6S2.
Calc.: C; 58.80%, H, 4.93%, N; 20.57%.
Zinc(II) bis(4-ethyl-3-thiosemicarbazone) acenaphthenequi-
none Zn(3). Gallium(III) chloride bis(4-allyl-3-thiosemicarba-
zone) acenaphthenequinone was prepared following the
method of Pascu et al. 2008.34
Zinc(II) bis(4-allyl-3-thiosemicarbazone) acenaphthenequi-
none Zn(4). Gallium(III) chloride bis(4-allyl-3-thiosemicarb-
azone) acenaphthenequinone was prepared following the
method of Pascu et al. 2007.32
Gallium(III) chloride bis(4-ethyl-3-thiosemicarbazone) ace-
naphthenequinone Ga(3). A suspension of zinc bis(4-ethyl-3-
thiosemicarbazone) acenaphthenequinone (0.216 g,
0.482 mmol) in MeOH (50 mL) was added to GaCl3 (0.420 g,
1.478 mmol). The resulting suspension was heated at reflux
for 6 h. The red solid that precipitated on cooling to room
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temperature was then isolated by filtration, washed with Et2O
and dried under vacuum (0.146 g, 0.299 mmols, 62%). The
(E,E) and (E,Z) isomers were found to be present in the integral
ratio of approximately 1 : 1 in d6-DMSO by
1H NMR analysis.
(E,Z) isomer (51%). 1H NMR (300 MHz, d6-DMSO, 25 °C): δ
9.58 (t, 1H, NH), 8.87 (t, 1H, NH′), 8.50 (d, 1H, H-1, J = 7.0 Hz),
8.11 (d, 1H, H-3′, J = 8.3 Hz), 8.03 (d, 1H, H-3, J = 8.1 Hz), 7.93
(d, 1H, H-1′, J = 6.9 Hz), 7.83 (apparent t, 1H, H-2), 7.76 (appar-
ent t, 1H, H-2′), 3.61 + 3.56 (m, 4H, CH2), 1.26 + 1.25 (two t,
6H, CH3, J = 7.2 Hz); (E,E) isomer (49%): δ 8.79 (broad t, 2H,
NH), 8.16 (d, 2H, H-1, J = 7.0 Hz), 8.09 (d, 2H, H-3, J = 8.3 Hz),
7.75 (apparent t, 2H, H-2), 3.59 (m, 4H, CH2), 1.25 (t, 6H, CH3,
J = 7.2 Hz). 13C NMR (75.5 MHz, d6-DMSO, 25 °C): δ 177.56,
173.20, 169.93, 138.72, 138.50, 135.84, 132.28, 130.25, 129.65,
129.31, 128.92, 128.47, 127.00, 126.83, 126.06, 124.23, 118.39,
114.13, 41.87, 38.34, 37.57, 14.60, 14.07, 13.67. Mass spectrum
ESI-MS Calc. for C18H17ClGaN6S2 [M − H]− 484.9900; found
484.9907.
Gallium(III) chloride bis(4-allyl-3-thiosemicarbazone) ace-
naphthenequinone Ga(4). Gallium(III) chloride bis(4-allyl-3-
thiosemicarbazone) acenaphthenequinone was prepared fol-
lowing the method of Pascu et al. 2011.21
Radiochemistry labelling procedures
10 mL of 0.1 M HCl was used to elute ca. 222 MBq of 68Ga3+
from the generator and was subsequently trapped on a 30 mg
mL−1 Strata X-C cartridge. This was eluted with 700 μL of
0.02M HCl/98% acetone and dried for 15 min under a stream
of nitrogen or argon at 110 °C Alternatively, 1 N aq. HCl may
also be used. Next, 25 μL of 2 mg mL−1 zinc complex precursor
in DMSO and 2 mL of HPLC-grade THF were added. The solu-
tion was heated for 30 min at 90 °C, or via a microwave for
10 min set to 90 °C. The HPLC methods above were used to
analyse the reaction mixtures.
Cell culturing and cell plate preparation
Cells were cultured at 37 °C, at 5% CO2 in a humidified atmos-
phere and passaged once confluence had been reached.
Culture occurred in Eagle’s Minimum Essential Medium
(EMEM) for HeLa (human cervical cancer cells) and FEK-4 (epi-
thelial fibroblast cells), Dulbecco’s Modified Eagle’s Medium
(DMEM) for MCF-7 (human breast cancer), RPMI 1640 for PC3
(human prostate cancer cells) and Waymouth’s medium for
EMT6 (murine breast carcinoma cells). The media contained
foetal calf serum (FCS) (10% for HeLa, PC-3 and MCF-7 and
15% for FEK-4 and EMT6 cells), 0.5% penicillin/streptomycin
(10 000 IU mL−1/10 000 mg mL−1) and 200 mM L-Glutamine
(5 mL). All steps were performed in absence of phenol red.
Cells were trypsinised and counted using a haemocytometer
and then seeded as appropriate for the biological assays.
Fluorescence microscopy
Confocal fluorescence microscopy experiments were carried
out on a Zeiss LSM510META microscope under normoxic con-
ditions. For all fluorescence microscopy experiments, cells
were cultured as above and plated in glass-bottomed dishes as
1.5 × 105 cells per dish (ca. 60% coverage) and incubated for
12 h for HeLa, EMT-6 and FEK-4 cells. All steps were carried
out in the absence of phenol red. Prior to compound addition,
cells were washed 3 times with PBS, before adding serum free
medium (1 mL). Subsequently, a small volume of medium was
removed (10 μL) and compound in DMSO was added to obtain
a final volume of 1 mL and the desired concentration. The
final concentration of compounds on the cell plate was 50 μM
in medium, containing 0.5% DMSO or 1% DMSO, depending
on the compound solubility. After 20 min with the compound
cells were washed 3 times with PBS and fresh serum free
medium was added (1 mL) and images were recorded
immediately.
Flow cytometry studies
Cells were seeded as 3 × 105 cells per well in a 6 well plate and
incubated overnight. The cells were subsequently washed twice
with PBS before incubation with the compound at 50 µM, 4%
DMSO final concentration in serum free media. This was
incubated for 20 min at 20.7% O2 and 5% CO2 at 37 °C for
normoxic samples. Hypoxic conditions were obtained by pre-
incubating the cells for 20 min at 1% O2 and 5% CO2 at 37 °C,
followed by incubation for a further 20 min under the same
conditions with the compound. Following this, cells were
washed three times with PBS, trypsinised and centrifuged at
600g for three min. The pellet was washed with PBS, re-
suspended in 1 mL of serum free medium, kept on ice and
analysed with a LSRII cytometer (BD Biosciences, Rockville,
MD USA), with 10 000 cells counted per event. Each experiment
was carried out at least three times, with data analysis per-
formed using FlowJo software (TreeStar, USA).
Radioactive cell retention investigation
Cells were seeded as 3 × 105 cells per well in a 6 well plate and
incubated for ca. 12 h. The cell medium was aspirated and
replaced with serum free medium containing the 68Ga radio-
labelled complex (following the radiochemistry procedure
above). This was incubated at 20.7% O2 and 5% CO2 at 37 °C
for normoxia. Hypoxic conditions were obtained by pre-incu-
bating the cells for 20 min at 1% O2 and 5% CO2 at 37 °C, fol-
lowed by incubation under the same conditions with the
compound for the time course of the study. Cell plates were
subsequently placed on ice, washed 3 times with ice-cold PBS
and lysed using 0.2 mL RIPA buﬀer for 10 min (Thermo Fisher
Scientific Inc., Rockford, IL, USA). PBS (0.5 mL) was added to
each well and cell lysates were transferred to counting tubes,
with measurements of decay-corrected radioactivity performed
using a gamma counter (Cobra II Auto-Gamma counter,
Packard Biosciences Co, Pangbourne, UK). Aliquots were snap-
frozen and subsequently protein determination was carried
out using a bicinchoninic acid assay (BCA) assay (Thermo
Fisher Scientific Inc., Rockford, IL, USA). Decay corrected
counts were corrected to protein concentration, with data pre-
sented as percent of total radioactivity per mg of protein.
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Statistical analysis
Data were expressed as mean ± standard error of the mean
(SEM), unless stated in the text. Student’s t test (Prism v5.0
software for windows, GraphPad Software, San Diego, CA, USA)
was used to assess the significance of comparison between two
data sets. If P ≤ 0.05 the diﬀerences between groups were
regarded as significant.
X-ray crystallography
Crystal data for 3. C36H38N12S4, M = 767.02, a = 8.535(2) Å,
b = 19.120(5) Å, c = 22.172(6) Å, α = 90°, β = 90°, γ = 90°, V =
3618.2(16) Å3, T = 100(2) K, space group P 21 21 21, Z = 4, μ(syn-
chrotron) = 0.242 mm−1, 28 222 reflections measured, 6895
independent reflections (Rint = 0.2717). The final R1 values
were 0.0993 (I > 2σ(I)). The final wR(F2) values were 0.2565 (I >
2σ(I)). The final R1 values were 0.1037 (all data). The final wR
(F2) values were 0.2666 (all data). The goodness of fit on F2 was
1.061. Flack parameter = 0.10(18). CCDC 1001632.
Crystal data for 4. C20H20N6S2, M = 408.54, a = 7.859(7) Å,
b = 11.040(9) Å, c = 12.049(9) Å, α = 90.546(6)°, β = 95.3880(10)°,
γ = 110.304(13)°, V = 975.1(14) Å3, T = 293(2) K, space group P1ˉ,
Z = 2, μ(synchrotron) = 0.227 mm−1, 6825 reflections
measured, 3176 independent reflections (Rint = 0.0509). The
final R1 values were 0.0573 (I > 2σ(I)). The final wR(F2) values
were 0.1398 (I > 2σ(I)). The final R1 values were 0.0802 (all
data). The final wR(F2) values were 0.1510 (all data). The good-
ness of fit on F2 was 1.049. CCDC 1001633.
Crystal data for Ga(3). C18H18ClGaN6S2·2(C2H6OS), M =
643.93, a = 11.55230(10) Å, b = 11.7595(3) Å, c = 12.0749(3) Å,
α = 114.468(2)°, β = 105.4834(17)°, γ = 93.4737(18)°, V =
1411.20(6) Å3, T = 150(2) K, space group P1ˉ, Z = 2, μ(MoKα) =
1.397 mm−1, 50963 reflections measured, 12 291 independent
reflections (Rint = 0.0414). The final R1 values were 0.0445 (I >
2σ(I)). The final wR(F2) values were 0.1019 (I > 2σ(I)). The final
R1 values were 0.0695 (all data). The final wR(F2) values were
0.1163 (all data). The goodness of fit on F2 was 1.023. CCDC
1001634.
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